We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+25.16%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.46B
AUM Growth
+$147M
Cap. Flow
-$82.7M
Cap. Flow %
-5.66%
Top 10 Hldgs %
25.13%
Holding
215
New
28
Increased
57
Reduced
41
Closed
25

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$31.1M
2
MRK icon
Merck
MRK
+$27.8M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$24.3M
4
IMGN
Immunogen Inc
IMGN
+$14.5M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$14.1M

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$29.3M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$28.4M
3
UTHR icon
United Therapeutics
UTHR
+$26.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$25.8M
5
PODD icon
Insulet
PODD
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 53.92%
2 Technology 13.34%
3 Industrials 8.74%
4 Consumer Discretionary 4.85%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDNS icon
51
Cadence Design Systems
CDNS
$93.4B
$7.55M 0.52%
32,174
-986
-3% -$215K
SNPS icon
52
Synopsys
SNPS
$79.7B
$7.23M 0.49%
16,613
-511
-3% -$206K
CALY
53
Callaway Golf Company
CALY
$3.14B
$7.16M 0.49%
360,584
-358,615
-50% -$7.18M
MTZ icon
54
MasTec
MTZ
$21.9B
$6.89M 0.47%
58,385
+4,223
+8% +$414K
TPH
55
DELISTED
Tri Pointe Homes
TPH
$6.88M 0.47%
209,419
+47,088
+29% +$1.38M
DSGX icon
56
Descartes Systems
DSGX
$6.82B
$6.8M 0.46%
84,857
– –
CROX icon
57
Crocs
CROX
$6.55B
$6.74M 0.46%
59,938
+21,560
+56% +$2.57M
TDG icon
58
TransDigm Group
TDG
$67.7B
$6.49M 0.44%
7,263
+1,663
+30% +$1.32M
PSN icon
59
Parsons
PSN
$5.08B
$6.31M 0.43%
131,097
+88,613
+209% +$4.04M
TEX icon
60
Terex
TEX
$7.74B
$6.24M 0.43%
104,238
-19,219
-16% -$953K
AMD icon
61
Advanced Micro Devices
AMD
$789B
$6.12M 0.42%
53,760
– –
BRBR icon
62
BellRing Brands
BRBR
$1.34B
$6.12M 0.42%
+167,240
New +$6M
AAPL icon
63
Apple
AAPL
$4.57T
$6.12M 0.42%
31,532
+8,659
+38% +$1.51M
CXT icon
64
Crane NXT
CXT
$3.07B
$6M 0.41%
+106,260
New +$5.4M
CLH icon
65
Clean Harbors
CLH
$16.3B
$5.58M 0.38%
33,935
– –
RRX icon
66
Regal Rexnord
RRX
$11.9B
$5.35M 0.37%
34,740
– –
VICI icon
67
VICI Properties
VICI
$29.4B
$5.2M 0.36%
165,606
-46,814
-22% -$1.5M
EXE
68
Expand Energy Corp
EXE
$21.5B
$5.15M 0.35%
61,500
– –
CFLT
69
DELISTED
Confluent
CFLT
$5.06M 0.35%
143,428
+44,608
+45% +$1.25M
MGPI icon
70
MGP Ingredients
MGPI
$375M
$4.91M 0.34%
46,245
+64
+0.1% +$6.4K
TREX icon
71
Trex
TREX
$5.01B
$4.9M 0.33%
74,683
+22,083
+42% +$1.23M
DKS icon
72
Dick's Sporting Goods
DKS
$18.7B
$4.81M 0.33%
36,387
-2,774
-7% -$380K
WFRD icon
73
Weatherford International
WFRD
$6.22B
$4.79M 0.33%
+72,120
New +$4.44M
SXI icon
74
Standex International
SXI
$4.12B
$4.78M 0.33%
33,809
+4,622
+16% +$610K
LVS icon
75
Las Vegas Sands
LVS
$29.6B
$4.77M 0.33%
82,212
+11,908
+17% +$704K
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Nicholas Investment Partners held 215 positions worth $1.46B, up 11% from $1.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Nicholas Investment Partners withdrew a net $82.7M in Q2 2023, closing 25 positions and reducing 41 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $29.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 53% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Intra-Cellular Therapies Inc. worth $31.6M.

  • Nicholas Investment Partners's largest Q2 2023 buy was Intra-Cellular Therapies Inc.: 499,503 shares worth $31.6M.
  • Nicholas Investment Partners added most to Xenon Pharmaceuticals in Q2 2023, an estimated $14.1M increase.
  • Nicholas Investment Partners's biggest Q2 2023 reduction was Lantheus, cutting an estimated $9.72M.
  • Nicholas Investment Partners fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $29.3M.
  • Nicholas Investment Partners's ten largest holdings make up 25% of its $1.46B portfolio in Q2 2023.
  • Nicholas Investment Partners opened 28 new positions and closed 25 in Q2 2023.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.46B.

Based on Nicholas Investment Partners's 13F filing for Q2 2023, filed 10 Aug 2023.